Peter Svennilson, Director at Revolution Medicines, Inc. (RVMD), sold 130,258 shares at $44.80 ($5.8M) on 2021-04-08, disclosed to the SEC on 2021-04-12.
Open-market sale of $5.8M RVMD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.80 | 21,710 | $973K | 16.8% |
| 2 | $44.80 | 21,710 | $973K | 16.8% |
| 3 | $44.80 | 24,518 | $1.1M | 18.9% |
| 4 | $44.80 | 24,518 | $1.1M | 18.9% |
| 5 | $43.83 | 11,600 | $508K | 8.8% |
| 6 | $43.83 | 13,101 |
| $574K |
| 9.9% |
| 7 | $43.83 | 13,101 | $574K | 9.9% |
| Total | $44.52 avg | 130,258 | $5.8M | 100% |
| Filing → |
| NGM | BUY | 2022-06-06 | $877K | — | Filing → |
| NGM | BUY | 2022-05-19 | $4.0M | — | Filing → |
| RAPT | SELL | 2021-08-24 | $5.4M | — | Filing → |